CDC panel recommends full FDA approval for Moderna COVID-19 vaccine

A key advisory panel for the Centers for Disease Control and Prevention voted to give full approval to Moderna’s COVID-19 vaccine more than a year after it was granted an emergency use authorization.

The CDC’s Advisory Committee on Immunization Practices voted 13-0 to recommend full approval for Moderna’s two-dose vaccine series for ages 18 years and older, marketed as Spikevax, after receiving full approval from the Food and Drug Administration earlier this week, according to CNN.